Dr Reddy's Laboratories's market cap is currently $11.28B. The company's EPS TTM is $0.769; its P/E ratio is 17.46; and it has a dividend yield of 0.60%. Dr Reddy's Laboratories is scheduled to report earnings on January 23, 2025, and the estimated EPS forecast is $0.21. See an overview of income statement, balance sheet, and cash flow financials.

	Mar 24	Mar 23	Mar 22	Mar 21	Mar 20
Income Statement
Total Revenue	₹ 279.16B	₹ 245.88B	₹ 214.39B	₹ 189.72B	₹ 174.60B
Gross Profit	₹ 163.61B	₹ 202.97B	₹ 113.84B	₹ 103.08B	₹ 94.01B
Operating Income	₹ 67.73B	₹ 96.28B	₹ 40.82B	₹ 36.06B	₹ 37.05B
EBITDA	₹ 88.42B	₹ 74.43B	₹ 47.74B	₹ 45.71B	₹ 41.78B
Net Income	₹ 55.68B	₹ 45.07B	₹ 23.57B	₹ 17.24B	₹ 19.50B
Balance Sheet
Cash & Short-Term Investments	₹ 81.47B	₹ 66.75B	₹ 44.37B	₹ 34.57B	₹ 25.74B
Total Assets	₹ 387.52B	₹ 322.85B	₹ 296.65B	₹ 265.49B	₹ 232.24B
Total Debt	₹ 20.02B	₹ 13.47B	₹ 33.84B	₹ 30.31B	₹ 22.10B
Net Debt	₹ 12.91B	₹ 7.69B	₹ 18.99B	₹ 15.48B	₹ 20.05B
Total Liabilities	₹ 106.97B	₹ 89.99B	₹ 106.13B	₹ 90.51B	₹ 77.25B
Stockholders' Equity	₹ 280.55B	₹ 232.86B	₹ 190.53B	₹ 174.98B	₹ 154.99B
Cash Flow
Free Cash Flow	₹ 18.00B	₹ 40.01B	₹ 9.06B	₹ 23.14B	₹ 23.73B
Operating Cash Flow	₹ 45.43B	₹ 58.87B	₹ 28.11B	₹ 35.70B	₹ 29.84B
Investing Cash Flow	₹ -40.28B	₹ -41.37B	₹ -26.39B	₹ -22.66B	₹ -4.92B
Financing Cash Flow	₹ -3.76B	₹ -26.86B	₹ -2.42B	₹ -298.00M	₹ -25.16B

Currency in INR

Dr Reddy's Laboratories Earnings and Revenue History

Income Statement >

Dr Reddy's Laboratories Debt to Assets

Balance Sheet >

Dr Reddy's Laboratories Cash Flow

Cash Flow >

Dr Reddy's Laboratories Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing